This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Emcure Pharmaceuticals Limited With a market cap of Rs. Foreign investor BC Investments IV Limited offloaded around 45 lakh equity shares, equivalent to a 2.37 As per the latest shareholding pattern with the BSE, BC Investments IV Limited held an 8.68 Investing in equities poses a risk of financial losses.
Emcure Pharmaceuticals Emcure Pharmaceuticals Limited’s stock, with a market capitalisation of Rs. According to CNBC-TV18, BC Investments IV, backed by Bain Capital, is planning to sell a 2.4% According to CNBC-TV18, BC Investments IV, backed by Bain Capital, is planning to sell a 2.4% 23,762 crores, fell to Rs.
Market: This is perhaps one of our favorite articles and times of the year; not necessarily because of basketball but rather it allows us the opprtunity to articulate our main investment themes we see playing out for the remainder of the year. Who will be this years champion? Lets break it down ( click here to see the full bracket).
It is widely used by value investors to identify attractive investment opportunities. It manufactures and markets glass containers, PET bottles, and packaging solutions for beverages, pharmaceuticals, cosmetics, and other industries. Investing in equities poses a risk of financial losses. per share, up by 1.32
Dr Reddy’s Laboratories Ltd Dr. Reddy’s Laboratories is a leading Indian pharmaceutical company known for manufacturing generic drugs, active pharmaceutical ingredients (APIs), and biosimilars. Investing in equities poses a risk of financial losses. Please consult your investment advisor before investing.
31,09,000 if someone had invested in 2020 and held the share till the peak in September of 2024. The Other segment encompasses the distribution of pharmaceutical products and the company’s agribusiness initiatives, reflecting Nava’s strategic diversification into healthcare and agriculture. 674 in September of 2024.
The company serves sectors like pharmaceuticals, agrochemicals, and industrial applications. Glenmark Pharmaceuticals Ltd Glenmark Pharmaceuticals is a global pharmaceutical company headquartered in India, focused on generics, specialty, and over-the-counter (OTC) products. 4,950 on May 15, 2023.
Here are three companies with a Six-months lock-in expiry on June 30, 2025 Senores Pharmaceuticals Limited With a market capitalization of Rs. crore, the shares of Senores Pharmaceuticals Limited were currently trading at Rs. On June 30, 2025, the six-month lock-in period for Senores Pharmaceuticals ends, unlocking 2.2
Cohance Lifesciences Cohance Lifesciences is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals, and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies.
Aarti Pharmalabs Limited was established in 2019 and is engaged in manufacturing active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives. It is also engaged in contract development and manufacturing services for global pharmaceutical companies. per equity share, down nearly 2.18
Overall, investing in low-beta stocks can be a strategic move for investors who want to minimize their exposure to market volatility, protect their portfolios against downturns, and potentially achieve long-term outperformance. Investing in equities poses a risk of financial losses. The net profit of the company has decreased by 32.97
They can reshape sectors and industries and impact your investment decisions. Let’s dive into some of the key future investment trends and concerns that are already making waves in 2025 and are likely to gain even more momentum in the months ahead. 4 future investment trends and concerns to keep an eye on in 2025 1.
Cipla Ltd Cipla Limited is a global pharmaceutical company headquartered in Mumbai, India, known for its wide range of medicines in respiratory, anti-retroviral, urology, cardiology, and other segments. Investing in equities poses a risk of financial losses. Please consult your investment advisor before investing.
Finance & Investments Even yet the unchallenged champion, finance has traditionally been the incubator of billionaires. From hedge fund kings and private equity masters to investment bankers and wealth managers, the world of finance provides virtually unparalleled conditions for compound growth of capital.
While the total investment value remains unchanged, shareholders receive more shares, promoting broader ownership and trading activity. Anuh Pharma Ltd Anuh Pharma Limited is engaged in the business of manufacturing active pharmaceutical ingredients (API). Investing in equities poses a risk of financial losses.
RPG Life Sciences Limited is engaged in the business of manufacturing and marketing Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Written by Shivani Singh Disclaimer The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in
Spotting such stocks early, especially in high-growth sectors or fundamentally strong companies, can offer attractive investment opportunities. Written By – Nikhil Naik Disclaimer The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in on June 5, 2025.
However, the Pharma index bucked the trend and posted gains, led by a significant rally in Glenmark Pharmaceuticals after a favourable licensing agreement. Disclaimer The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in Despite this, the Nifty Pharma index gained 149.10
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited was founded in 1907 and is an Indian multinational headquartered in Vadodara. It manufactures and markets pharmaceutical formulations, active pharmaceutical ingredients, and intermediates, with a strong presence in anti-infective drugs and global markets.
When examining what truly drives long-term investment success, the steady progression of a company’s operational excellenceits “fundamental momentum”deserves particular attention. Discover how Valideas models can help you identify high-quality, long-term investments, even in changing market conditions.
This Week: Companies Reporting Earnings Monday: Vertex Pharmaceuticals Incorporated (VRTX) Tuesday: Apollo Global Management Inc. Investing involves risks, and investment decisions should be based on your own goals, time horizon, and tolerance for risk. When sold, investments may be worth more or less than their original cost.
As per the latest bulk deal on BSE, a foreign institutional investment (FII), Schroder International Selection Fund Asian Total Return, purchased around 53.7 Written by Shivani Singh Disclaimer The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in 180 on Friday.
And the firm is really a very interesting mix of quantitative value-based and factor-based investing. People ask how does that relate to investing? How did that background help when it comes to modeling portfolios or applying those methods of statistical analysis to investing? It’s really none and all of the above.
Wealth First Portfolio Managers Limited Wealth First Portfolio Managers is a financial services company that offers wealth management and investment advisory services to individuals and institutions. They focus on creating personalized investment portfolios based on clients’ goals and risk tolerance. With a market capitalization of Rs.
Zota Health Care Limited is a drug development, manufacturing and marketing company, offering a wide range of pharmaceutical, nutraceutical, ayurvedic and OTC products in India and overseas as well. Investing in equities poses a risk of financial losses. Please consult your investment advisor before investing.
Huang discovered that combining fundamental and price momentum creates a more powerful investment strategy than either approach alone. Visit Validea.com to access in-depth stock analysis and tools designed to emulate proven investment principles. 1 AMPH AMPHASTAR PHARMACEUTICALS INC $26.66 $1,270 8.7 Take a Free Trial Today!
Bliss GVS Pharma Limited was established in 1984 and is an Indian pharmaceutical company that develops, manufactures, and markets a wide range of affordable medicines and healthcare products, with global exports and leadership in suppositories and anti-malarial formulations. Investing in equities poses a risk of financial losses.
Mankind Pharma Ltd Mankind Pharma is one of India’s leading pharmaceutical companies. Written by Sridhar J Disclaimer The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in Investing in equities poses a risk of financial losses.
Marksans Pharma Limited is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. According to sources, Jomei Investments, a special purpose vehicle (SPV) backed by Advent International Corporation, had initiated the block deal on 10th June to divest a 1.4 on Wednesday.
Suven Life Science Ltd Suven Life Science Ltd is a pharmaceutical and biotechnology company specializing in drug discovery and contract research services. It focuses on developing novel therapeutics for central nervous system disorders and collaborates with global pharmaceutical firms.
Foreign Investments (FII and FDI): Foreign investors bring dollars into India through the stock market (FII) and businesses (FDI). When investors believe India is a safe investment, there is more dollar inflow, which strengthens the rupee. This improves sectors like IT, textiles, pharmaceuticals, etc.
Zydus Lifesciences Ltd Zydus Lifesciences, formerly Cadila Healthcare, is a leading Indian multinational pharmaceutical company headquartered in Ahmedabad. Written By Sridhar J Disclaimer The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in
It works with global clients, including biotech startups and large pharmaceutical firms, helping them bring new medicines to market. Strong global customer base, including large pharmaceutical and biotech companies. Robust R&D capabilities and investment in advanced technologies.
So investing in these stocks can provide you with passive income and growth in your portfolio over time. Pfizer Ltd Pfizer Ltd is the Indian arm of the global pharmaceutical giant Pfizer Inc. Dr Reddy’s Laboratories Ltd Dr Reddy’s is a multinational pharmaceutical company headquartered in Hyderabad. 1 per share.
It offers investment banking, mortgage lending, asset management, wealth management, and distressed credit solutions to clients in India and internationally. Pfizer Limited Pfizer Limited was incorporated in 1950 and is the Indian subsidiary of global pharmaceutical giant Pfizer Inc. with decent volumes of 13.64 million shares.
Then look forward to see how the list changes over time to spot emerging trends and to consider what has changed and what hasn’t, and how this information may impact your investment thesis. You can watch how those changes occur, from 1980-2020, below. I started driving in 1972. Gasoline was $0.36 per gallon. percent).
Glenmark Pharmaceuticals Limited Glenmark Pharmaceuticals Limited was established in 1977 and is engaged in the research, development, manufacturing, and marketing of pharmaceutical formulations and active pharmaceutical ingredients, focusing on oncology, respiratory, and dermatology segments globally.
Among the contracts and orders the business recently signed was a non-binding term agreement for a municipal platform to focus on the development of capital projects for the municipal sector with an equity investment commitment of $100 million in capital projects over a three- to five-year period. points, or 0.68%.
is an engineering and construction company that specializes in turnkey EPC (Engineering, Procurement, and Construction) projects across various sectors, including industrial, commercial, institutional, pharmaceutical, and renewable energy. Investing in equities poses a risk of financial losses.
blogs.cfainstitute.org) AI The Meta ($META) 'investment' in Scale AI is done. spyglass.org) Pharmaceuticals How pharmacy benefit managers (PBMs) work. abnormalreturns.com) Everyone in life (and investing) is running their own race. riabiz.com) On the growth in search funds. theincidentaleconomist.com) U.S.
Its customer base spans sectors such as energy, metals, infrastructure, and pharmaceuticals, showcasing Suzlon’s wide market reach and strong trust among top corporations in renewable energy solutions. Investing in equities poses a risk of financial losses. Please consult your investment advisor before investing.
The shares of prominent pharmaceutical companies gained up to 4 percent in today’s trading session after the company signed definitive agreements with global investment firm KKR to acquire a controlling stake in JB Chemicals & Pharmaceuticals worth Rs 25,689 crores on a fully diluted basis. per share, increasing around 0.19
Shares of a company involved in exporting, marketing & distributing finished formulations of pharmaceutical drugs and API surged nearly 3 percent on Tuesday, after the company announced record date for bonus issue in 1:1 ratio. the shares of Remus Pharmaceuticals Limited were trading in the green at Rs. With a market cap of Rs.
It is a leading manufacturer and supplier of industrial gases like oxygen, nitrogen, argon, helium, hydrogen, carbon dioxide, and more, catering to a wide range of industries such as steel, shipbuilding, glass, pharmaceuticals, and fabrication. Investing in equities poses a risk of financial losses.
We organize all of the trending information in your field so you don't have to. Join 36,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content